Publication date: Available online 5 November 2026 Source: Ophthalmology Glaucoma Author(s): Kyle Bolo, Brandon J. Wong, Jiun L. Do, Jose-Luis Ambite, Zhiwei Li, Carl Kesselman, Lauren P. Daskivich, Benjamin Y. Xu
Incidence and Predictors of IOP-Lowering Treatment Following Detection of Referable Glaucoma in a Teleretinal Screening Program. // Ophthalmology Glaucoma. – URL: https://www.sciencedirect.com/science/article/pii/S2589419626001754?dgcid=rss_sd_all
Incidence and Predictors of IOP-Lowering Treatment Following Detection of Referable Glaucoma in a Teleretinal Screening Program. Ophthalmology Glaucoma. https://www.sciencedirect.com/science/article/pii/S2589419626001754?dgcid=rss_sd_all
“Incidence and Predictors of IOP-Lowering Treatment Following Detection of Referable Glaucoma in a Teleretinal Screening Program.” Ophthalmology Glaucoma.
@article{article60823,
title = {Incidence and Predictors of IOP-Lowering Treatment Following Detection of Referable Glaucoma in a Teleretinal Screening Program},
journal = {Ophthalmology Glaucoma},
url = {https://www.sciencedirect.com/science/article/pii/S2589419626001754?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...